Skip to content
Screener

RxSight, Inc. RXST Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$30.3MMiss by $2.3M
EPS-$0.04Beat by $0.15
Revenue estimate$32.6M
EPS estimate-$0.19

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$27.2M
EPS estimate-$0.29

Financials

Q3 2025

Income statement

See full
Revenue$30.3M-14.1%
Gross profit$24.2M-3.9%
Operating income-$12.2M-32.0%
Net income-$9.8M-54.9%
EPS (diluted)-$0.24-50.0%

Balance sheet

See full
Cash & equivalents$29.6M+77.2%
Total debt$11.6M+2.3%
Total equity$276.0M-0.5%
Total assets$308.5M-0.6%

Cash flow

See full
Operating cash flow-$1.2M—
CapEx$581.0K-47.3%
Free cash flow-$1.8M-290%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$367.83M-80.6%
Enterprise value$349.77M-81.5%
P/S2.6×-12.2×

Profitability

See full
Gross margin75%+6.5pp
Operating margin-32%+1.7pp
Net margin-25.1%+1.4pp
FCF margin-15.6%-3.2pp

Returns & leverage

See full
Return on equity-12.9%-0.9pp
Debt / equity0×0.0×
Current ratio12.7×+0.1×

Segments

By product

See full
Rxlal$25.7M+6.0%
LDD$3.2M-68.7%
Service Warranty Service Contracts And Accessories$1.5M+54.2%

FAQ

When did RxSight, Inc. report Q3 2025 earnings?
RxSight, Inc. (RXST) reported Q3 2025 earnings on November 5, 2025 after market close.
What were RxSight, Inc.'s Q3 2025 revenue and EPS?
RxSight, Inc. reported revenue of $30.3M and eps of $-0.04 for Q3 2025.
Did RxSight, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $32.6M by $2.3M. EPS beat the consensus estimate of $-0.19 by $0.15.
How did RxSight, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 33.2% from $45.4M a year earlier and eps grew 75.0% from $-0.16.
Where can I find RxSight, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-266938) and the 10-Q periodic report (0001193125-25-266986) directly on SEC EDGAR. The filing index links above go to sec.gov.